Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome

被引：6
|
作者：
Dunoyer-Geindre, Sylvie [1 ]
Boehlen, Francoise [1 ]
Favier, Remi [2 ]
Wahl, Denis [3 ]
Musial, Jacek [4 ]
Korte, Wolfgang [5 ]
Satta, Nathalie [1 ]
Kruithof, Egbert [1 ]
de Moerloose, Philippe [1 ]
机构：
[1] Univ Hosp Geneva, Haemostasis Unit, Geneva, Switzerland
[2] Trousseau Hosp, AP HP, Haematol Dept, Paris, France
[3] Dept Med, Nancy, France
[4] Jagiellonian Univ Med Coll, Dept Med, Krakow, Poland
[5] Kantonsspital, Inst Klin Chem & Hamatol, St Gallen, Switzerland
来源：
HAEMATOLOGICA | 2008年 / 93卷 / 04期
基金：
瑞士国家科学基金会;
关键词：
antiphospholipid syndrome; antiphospholipid antibodies; immune thrombocytopenic purpura; endothelial cell activation;
D O I：
10.3324/haematol.12358
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 636
页数：2
相关论文
共 50 条
  • [21] Risk of thrombosis associated with antiphospholipid antibodies in immune thrombocytopenic Purpura: A single center retrospective study of 152 patients
    Fayard, Damien
    Lobbes, Herve
    Pereira, Bruno
    Ruivard, Marc
    THROMBOSIS RESEARCH, 2023, 221 : 7 - 9
  • [22] Endothelial cell activation by antiphospholipid antibodies
    Meroni, PL
    Raschi, E
    Testoni, C
    Borghi, MO
    CLINICAL IMMUNOLOGY, 2004, 112 (02) : 169 - 174
  • [23] Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome
    Glynne, P
    Salama, A
    Chaudhry, A
    Swirsky, D
    Lightstone, L
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (01) : 133 - 137
  • [24] Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura
    Ma, Daoxin
    Dai, Jianjian
    Zhu, Xiaojuan
    Yan, Shuxin
    Zhao, Ping
    Zhang, Jingru
    Zhu, Yuanyuan
    Sun, Jianzhi
    Peng, Jun
    Ji, Chunyan
    Hou, Ming
    ANNALS OF HEMATOLOGY, 2010, 89 (02) : 155 - 161
  • [25] Plasma microRNAs characterising patients with immune thrombocytopenic purpura
    Zuo, Bin
    Zhai, Juping
    You, Lifang
    Zhao, Yunxiao
    Yang, Jianfeng
    Weng, Zhen
    Dai, Lan
    Wu, Qingyu
    Ruan, Changgeng
    He, Yang
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (07) : 1420 - 1431
  • [26] Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
    Peerschke, Ellinor I. B.
    Andemariam, Biree
    Yin, Wei
    Bussel, James B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (04) : 638 - 645
  • [27] Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome
    Breen, Karen A.
    Seed, Paul
    Parmar, Kiran
    Moore, Gary W.
    Stuart-Smith, Sara E.
    Hunt, Beverley J.
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) : 423 - 429
  • [28] Plasma microRNA profiling of pediatric patients with immune thrombocytopenic purpura
    Bay, Ali
    Coskun, Enes
    Oztuzcu, Serdar
    Ergun, Sercan
    Yilmaz, Fatih
    Aktekin, Elif
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (04) : 379 - 383
  • [29] Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura
    Ravinder Naik Noonavath
    Chandrasekharan Padma Lakshmi
    Tarun Kumar Dutta
    Vikram Kate
    World Journal of Gastroenterology, 2014, (22) : 6918 - 6923
  • [30] Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients
    Hangaishi, Akira
    Takahashi, Tsuyoshi
    Masuda, Akiko
    Okada, Sumitaka
    Kandabashi, Koji
    Kurokawa, Mineo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 336 - 337
12345